95252 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
Sulfonylpyrroles
#4802PHARMACEUTICALLY ACTIVE DISUBSTITUTED TRIAZINE DERIVATIVES
#4803TRPV1 vanilloid receptor antagonists with a bicyclic portion
#4804Selective NR2B antagonists
#4805Substituted pyridines for modulating the WNT signaling pathway
#4806Heterocyclic compound and p27degradation inhibitor
#4807N-[(het)arylalkyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues
#4808THROMBOPOIETIN MIMETICS
#4809Formulations containing pyridazine compounds
#4810Substituted 2,4-diaminopyrimidines as kinase inhibitors
#4811TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
#4812Processes for preparing substituted pyrimidines
#4813Pyrrolidin-3-ylacetic acid derivative
#4814Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
#4815Pharmaceutical compounds
#48162,4-disubstituted pyrimidines useful as kinase inhibitors
#48174,6-diaminopyrimidines useful as kinase inhibitors
#4818Pyrimidine derivatives
#4819VLA-4 inhibitory drug
#4820Substituted 2,4-diaminopyrimidines as kinase inhibitors
#4821Compounds useful as Raf kinase inhibitors
#4822Zwitterionic reagents
#4823RADIOLABELED COMPOUNDS AND METHODS THEREOF
#4824Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV)
#4825Agonists of GPR131 and uses thereof
#4826Compounds for treating disease, for administering, and for pharmaceutical compositions
#4827PDE10 modulators
#4828Treatment of central nervous system disorders
#4829Antiviral compounds
#48301-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives for treating tumors
#4831Diaryl ether derivatives as notch sparing gamma secretase inhibitors
#4832Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease
#4833Heterocyclic compounds and uses thereof
#4834Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
#4835Pyrimidline derivatives having immune modulating properties that act via TLR7 for the treatment of viral or allergic diseases and cancers
#4836Method for synthesizing Imatinib
#4837Pro-neurogenic compounds
#4838Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof
#4839Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
#48401,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors
#4841Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels
#4842PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER
#4843Type II Raf kinase inhibitors
#4844mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
#4845Compound
#4846Quinazoline derivatives
#4847Compound suitable for the treatment of synucleopathies
#4848Peptidomimetic sulfamide compounds and antiviral uses thereof
#4849Carbazole-based compound and organic light-emitting diode comprising the same
#4850Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
#48519-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5] undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
#4852Myosin light chain kinase inhibitor compounds, compositions and related methods of use
#4853N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
#4854PYRAZOLE P38 MAP KINASE INHIBITORS
#4855Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
#48561,2,4-triazine-4-amine derivatives
#4857Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
#4858COMPOUNDS AND THERAPEUTICAL USES THEREOF
#4859Glucokinase activators and methods of using same
#4860Cationic 4-aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof
#4861Pyrazole compounds as CRTH2 antagonists
#4862PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
#4863INDAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
#48641,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
#4865Benzamides
#4866MicroRNA Modulators and Method for Identifying and Using the Same
#4867Triazine Derivatives and their Therapeutical Applications
#4868Selective FAK inhibitors
#4869Peptidomimetic sulfamide compounds and antiviral uses thereof
#4870Organic electroluminescence device
#4871PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#4872Heterocyclic aspartyl protease inhibitors
#4873Acetylenic heteroaryl compounds
#4874Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases
#4875Substituted indazole derivatives active as kinase inhibitors
#4876RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF
#48775,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals
#4878Substituted imidazole derivates
#4879Process for preparing 6-substituted-1-(2H)-isoquinolinones and intermediate compound
#4880HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS
#4881Dicycloazaalkane derivatives, preparation processes and medical uses thereof
#4882COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
#4883Small molecule choline kinase inhibitors, screening assays, and methods for treatment of neoplastic disorders
#4884Cytoskeletal active rho kinase inhibitor compounds, composition and use
#4885Heterobicyclic carboxamides as inhibitors for kinases
#4886Pyrazinone derivatives, pharmaceutically acceptance salts thereof and their uses
#4887Derivatives of propargylamine having neuroprotective capacity for the treatment of Alzheimer's and Parkinson's diseases
#4888P38 MAP kinase inhibitors
#4889Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
#4890NOVEL SPIRO IMIDAZOLONE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE
#4891COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
#4892NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE
#4893Pesticides and uses thereof
#4894Pyridazine compounds for controlling invertebrate pests
#4895Pyridazine compounds for controlling invertebrate pests
#4896Pyridazine compounds for controlling invertebrate pests
#4897Modulators of ATP-binding cassette transporters
#4898Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#4899Sulfonyl amide derivatives for the treatment of abnormal cell growth
#4900CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES
#4901Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use
#4902Heterobicyclic carboxamides as inhibitors for kinases
#4903Heterobicyclic carboxamides as inhibitors for kinases
#4904Heterobicyclic carboxamides as inhibitors for kinases
#4905Compounds and compositions as protein kinase inhibitors
#4906Monocyclic Heteroaryl Compounds
#4907QUINAZOLINE DERIVATIVES
#4908Triazine compounds as PI3 kinase and mTOR inhibitors
#4909SUBSTITUTED ARYLIMIDAZOLONE AND TRIAZOLONE AS INHIBITORS OF VASOPRESSIN RECEPTORS
#4910Pyrazole derivatives as protein kinase modulators
#4911Cyclic amine BACE-1 inhibitors having a benzamide substituent
#4912Heterocyclic compound and organic light-emitting device comprising the same
#4913Hepatitis C virus inhibitors
#4914Process for the preparation of α-acyloxy β-formamido amides
#4915COMPOUNDS USEFUL FOR TREATING PREMATURE AGING AND IN PARTICULAR PROGERIA
#4916COMPOUNDS AND METHODS
#4917Amino-tetrazoles analogues and methods of use
#4918Benzylic oxindole pyrimidines
#4919PROCESS FOR THE PREPARATION OF SUBSTITUTED PROLYL PEPTIDES AND SIMILAR PEPTIDOMIMETICS
#4920CROSSLINKING REAGENTS, METHODS, AND COMPOSITIONS FOR STUDYING PROTEIN-PROTEIN INTERACTIONS
#49215-HT4 receptor agonists for the treatment of dementia
#4922Biarylamide inhibitors of leukotriene production
#4923Piperazines as antimalarial agents
#4924Imidazole derivative
#4925Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
#4926AMIDE COMPOUNDS USEFUL IN THERAPY
#4927Compounds for inhibiting cell proliferation in EGFR-driven cancers
#4928Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
#4929Substituted 2-imidazolidones and analogs
#4930N-benzylindole modulators of PPARG
#4931Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
#4932Screening method and compounds for modulating telomerase activity
#4933N-biphenylmethylindole modulators of PPARG
#4934Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors
#4935Compounds
#4936Cyclic benzimidazole derivatives useful as anti-diabetic agents
#4937Neprilysin inhibitors
#4938Intermediates useful in the preparation of maleimide functionalized polymers
#4939Carbazole derivative with heteroaromatic ring, and light-emitting element, light-emitting device, and electronic device using carbazole derivative with heteroaromatic ring
#4940Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
#4941Phenyl and benzodioxinyl substituted indazoles derivatives
#4942Method of using PI3K and MEK modulators
#4943Clozapine immunoassay
#4944CLOZAPINE IMMUNOASSAY
#4945Chemokine receptor binding heterocyclic compounds with enhanced efficacy
#4946Ethers, secondary amines and derivatives thereof as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto
#4947Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases
#4948Hematopoietic growth factor mimetic small molecule compounds and their uses
#4949Substituted bicyclic triazole derivatives as gamma secretase modulators
#4950Substituted triazole derivatives as gamma secretase modulators
#4951Complement pathway modulators and uses thereof
#4952Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
#4953Substantially Stereomerically Pure Fused Bicyclic Proline Compounds and Processes for Preparing Boceprevir
#4954Compositions and methods for treating alzheimer's disease
#4955Pyridazinyl derivatives as smo inhibitors
#4956Inhibitors of diacylglycerol acyl transferase
#4957Fused heterocyclic compounds as ion channel modulators
#4958Modified carbocyanine dyes and their conjugates
#4959CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#4960Indole and azaindole modulators of the alpha 7 nachr
#4961Isoindolinone derivatives
#4962Compounds useful for treating AIDS
#4963Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase
#4964Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers
#4965Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal
#4966Chemical Compounds
#4967PYRAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
#4968Pyridine and pyrazine derivative for the treatment of CF
#4969COMPOUNDS USEFUL FOR TREATING CANCER
#4970Imidazole derivatives as IDO inhibitors
#4971PYRAZINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS
#4972BENZAMIDE COMPOUND
#4973Heterocyclic acrylamides and their use as pharmaceuticals
#4974Derivatives of N-[(1-pyrazol-1-yl)aryl]-1-indole or 1-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics
#4975PRODRUGS OF COMPOUNDS THAT INHIBIT TRPV1 RECEPTOR
#4976Dyes with changeable solubilities, and methods for their use
#4977Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
#4978PYRIMIDINE AMIDE COMPOUNDS
#4979Adamantyl diamide derivatives and uses of same
#4980(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors
#4981FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS
#4982Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
#4983INDOLINE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER
#4984Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
#4985Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors
#4986Ion channel modulators and methods of use
#4987Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
#49885-membered heterocycle-based P38 kinase inhibitors
#4989Aminobenzoquinazolinone M1 receptor positive allosteric modulators
#4990Benzyl substituted triazine derivatives and their therapeutical applications
#4991Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
#4992Amino-heteroaryl derivatives as HCN blockers
#4993Seven-membered ring compound and pharmaceutical use therefor
#4994Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
#4995Substituted phenylureas and phenylamides as vanilloid receptor ligands
#4996Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds
#4997Substituted pyrimidine compounds and uses thereof
#4998Amino-derivatives as novel inhibitors of histone deacetylase
#4999Chemical Compounds 572
#5000Heterobicyclic carboxamides as inhibitors for kinases
#5001Heterocyclic amine derivatives
#5002Inhibitors of the hedgehog pathway
#5003Pyridazine compounds, compositions and methods
#5004Biocatalytic processes for the preparation of stereomerically pure fused bicyclic proline compounds
#5005Use of oligomeric carbodiimides as stabilizers
#5006Compositions useful as inhibitors of voltage-gated sodium channels
#5007Inhibitors of the hedgehog pathway
#5008Substituted phenoxypropylcycloamine derivatives as histamine-3 (H) receptor ligands
#5009Compound
#5010AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF IKK EPSILON AND/OR TBK1
#5011Piperazine analogs as broad-spectrum influenza antivirals
#5012Edge-illuminated flat panel and light module for same
#5013Dipeptide mimics, libraries combining two dipeptide mimics with a third group, and methods for production thereof
#5014Methods of treating emesis using growth hormone secretagogues
#5015Novel Compounds
#5016PYRAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS
#5017Heterocyclic sulfonamides
#5018Pyrrolidin-3yl-methylamine quinoxaline derivatives
#5019Medicaments
#50202,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
#5021Use of Indole Derivatives as Nurr-1 Activators for the Application Thereof as a Medicament for the Treatment of Parkinson's Disease
#5022Quinazolines as potassium ion channel inhibitors
#5023Compounds
#5024Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
#5025PYRIDINE OR PYRIMIDINE DERIVATIVE HAVING EXCELLENT CELL GROWTH INHIBITION EFFECT AND EXCELLENT ANTI-TUMOR EFFECT ON CELL STRAIN HAVING AMPLIFICATION OF HGFR GENE
#5026Bicyclic compound, production and use thereof
#5027Organic compounds and their uses
#5028Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
#50294-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases
#5030(S)-6-(2-(4-(cyclobutylsulfonyl)-1H-imidazol-1-yl)-3-cyclopentylpropanamido)nicotinic acid useful as a glucokinase activator
#5031INDAZOLE ANALOG
#5032Glucokinase Activators
#5033Pyrrolidine derived beta 3 adrenergic receptor agonists
#5034Pyrazole compounds and thiazole compounds as protein kinases inhibitors
#5035COMPOUNDS
#5036Methods of preparing and using quinazoline and quinoline derivatives
#5037Androgen receptor modulating compounds
#5038Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
#5039Compounds for treating papilloma virus infection
#5040Materials for electronic devices
#5041Quinazoline compounds
#5042Heterocyclic compounds and methods of use
#50439-AMINOACRIDINE DERIVATIVES, THEIR PREPARATION AND USES
#5044MATERIALS FOR ELECTRONIC DEVICES
#5045N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo-1 (2H)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses
#5046Urotensin II receptor antagonists
#5047Aminoindane compounds and use thereof in treating pain
#5048COMPOSITIONS AND METHODS RELATING TO NOVEL COMPOUNDS AND TARGETS THEREOF
#5049Tetrazole-substituted arylamides as P2Xand P2Xantagonists
#50503H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents
#5051Cannabinoid receptor modulators
#5052Neprilysin inhibitors
#5053Compositions and methods for inhibition of the JAK pathway
#50543,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
#5055Compounds for the treatment of hepatitis C
#5056Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
#5057Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists
#5058Alpha adrenergic receptor modulators
#5059Heterocyclic compounds useful as PDK1 inhibitors
#5060Pyrrolidine derivatives as NK2 receptor antagonists
#5061Inhibitors of IAP
#5062Chemokine receptor antagonists and use thereof
#5063Glucagon receptor modulators
#5064UREIDOPHENYL SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
#5065Pyrazole-based thyroid receptor compounds
#5066COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF
#5067Triazole compounds that modulate HSP90 activity
#5068Heterocyclic compounds and methods of use
#5069USE OF PRODRUGS TO AVOID GI MEDIATED ADVERSE EVENTS
#5070Inhibitors of IAP
#5071Pesticidal compositions and processes related thereto
#5072Lactam-containing compounds and derivatives thereof as factor XA inhibitors
#5073Quinazoline derivatives as angiogenesis inhibitors
#5074COMPOSITIONS AND PROCESSES
#5075SIRTUIN MODULATING COMPOUNDS
#5076Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same
#5077NEW COMPOUNDS
#5078Histone deacetylase inhibitors based simultaneously on trisubstituted 1-pyrroles and aromatic and heteroaromatic spacers
#5079PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER
#5080Triazine derivatives and their therapeutical applications
#5081Wnt pathway antagonists
#5082THERAPEUTIC AGENT FOR CEREBRAL INFARCTION
#5083Antiviral compounds
#5084Process for preparation of high molecular weight molybdenum succinimide complexes
#5085Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
#5086APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#5087Bicyclo[3.2.1]octyl amide derivatives and uses of same
#5088Phenylimidazole derivative as PDE10A enzyme inhibitor
#5089Modulators for amyloid beta
#5090HCV protease inhibitors and uses thereof
#5091Pesticidal compositions
#5092Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
#5093PHENYLACETAMIDES SUITABLE AS PROTEIN KINASE INHIBITORS
#5094Compounds
#5095Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
#5096Dimeric IAP Inhibitors
#5097C-Met Modulators and Method of Use
#5098Glycine compound
#5099Screening method for enzyme inhibitors
#5100Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use